Hyaluronidase Via LADD Scleroderma-induced Microstomia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 24, 2024

Study Completion Date

September 24, 2024

Conditions
MicrostomiaScleroderma
Interventions
DRUG

Hyaluronidase

Hyaluronidase injection is used during fluid administration under the skin to help achieve hydration, to increase the dispersion and absorption of other injected drugs, or during some types of urography (imaging of the urinary tract) to help improve resorption of drugs used during the procedure.

DEVICE

CO2 laser

CO2 lasers use an aiming beam to see where the treatment beam will impact the focus tissue, which will then be cleanly incised. The CO2 lasers have greater precision for laser surgery and have more flexibility in tip sizes and protocols.

Trial Locations (2)

68105

University of Nebraska Medical Center, Lauritzen Outpatient Center, Omaha

68114

Nebraska Medicine, Dermatology Westroads, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT05995626 - Hyaluronidase Via LADD Scleroderma-induced Microstomia | Biotech Hunter | Biotech Hunter